BRAINLIFE Brain Tumor Medical Database

Etiology and Pathogenesis Molecular Oncology


PNAS, September 11, 2001, Vol. 98, No. 19, Pages 10851-10856. (Laboratory Investigation)
Published online before print August 28, 2001


Abstract

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

Q. Richard Lu, John K. Park, Elizabeth Noll, Jennifer A. Chan, John Alberta, Dongin Yuk, M. Garcia Alzamora, David N. Louis, Charles D. Stiles, David H. Rowitch, and Peter M. Black

Departments of Cancer Biology [Q.R.L., J.K.P, J.A., M.G.A., C.D.S.*] and Pediatric Oncology [D.Y., D.H.R.*], the Program in Neuro-oncology, Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Department of Neurosurgery [J.K.P., E.N., P.M.B.] and Neuropathology [J.A.C.], Brigham and Women's Hospital, Boston, MA 02115; Department of Pathology and Neurosurgical Service, Massachusetts General Hospital, Boston, MA 02129 [D.N.L.]; and Division of Newborn Medicine, Children's Hospital, Boston, MA 02115 [D.H.R.]. *To whom reprint requests should be addressed. E-mail: Chuck_Stiles@dfci.harvard.edu or David_Rowitch@dfci.harvard.edu. Communicated by Peter M. Howley, Harvard Medical School, Boston, MA, July 5, 2001 (received for review February 15, 2001).

The most common primary tumors of the human brain are thought to be of glial cell origin. 
However, glial cell neoplasms cannot be fully classified by cellular morphology or with conventional markers for astrocytes, oligodendrocytes, or their progenitors. 
Recent insights into central nervous system tumorigenesis suggest that novel molecular markers might be found among factors that have roles in glial development. 
Oligodendrocyte lineage genes (Olig1/2) encode basic helix-loop-helix transcription factors. 
In the rodent central nervous system, they are expressed exclusively in oligodendrocytes and oligodendrocyte progenitors, and Olig1 can promote formation of an chondroitin sulfate proteoglycon-positive glial progenitor. 
Here we show that human OLIG genes are expressed strongly in oligodendroglioma, contrasting absent or low expression in astrocytoma. 
Our data provide evidence that neoplastic cells of oligodendroglioma resemble oligodendrocytes or their progenitor cells and may derive from cells of this lineage. 
They further suggest the diagnostic potential of OLIG markers to augment identification of oligodendroglial tumors.


Source: http://www.pnas.org/cgi/content/abstract/98/19/10851
DOI: http://dx.doi.org/
10.1073/pnas.181340798
HTML Full Text: http://www.pnas.org/cgi/content/full/98/19/10851
PDF Full Text: http://www.pnas.org/cgi/reprint/98/19/10851


 

This website is certified by Health On the Net Foundation. Click to verify. HOMECURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTSBRAIN TUMOR MEDICAL DATABASE SERVICES TREATMENT OPTIONS FOR GLIOBLASTOMA
DATABASE by Section: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
DATABASE by Tumor: Glioblastoma | Medulloblastoma | Other TumorsSERVICES: About BrainLife | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications | Search | SiteMap
This site complies with the HONcode standard for trustworthy health information: verify here bottom